BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19683518)

  • 1. Glutamate dehydrogenase activity in lymphocytes of B-cell chronic lymphocytic leukaemia patients.
    Pajic T; Cernelc P; Sesek Briski A; Lejko-Zupanc T; Malesic I
    Clin Biochem; 2009 Nov; 42(16-17):1677-84. PubMed ID: 19683518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.
    Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F
    Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin.
    Campo S; Campo GM; Avenoso A; D'Ascola A; Musolino C; Calabrò L; Bellomo G; Quartarone E; Calatroni A
    Biochimie; 2006 Dec; 88(12):1933-9. PubMed ID: 16938379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients.
    Schisselbauer JC; Silber R; Papadopoulos E; Abrams K; LaCreta FP; Tew KD
    Cancer Res; 1990 Jun; 50(12):3562-8. PubMed ID: 2340505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interleukin-6 and interleukin-12 blood levels in patients with chronic B-cell lymphocytic leukemia].
    Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
    Pol Merkur Lekarski; 2004 Feb; 16(92):157-61. PubMed ID: 15176301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of reference genes for quantitative polymerase chain reaction studies in purified B cells from B cell chronic lymphocytic leukaemia patients.
    Valceckiene V; Kontenyte R; Jakubauskas A; Griskevicius L
    Br J Haematol; 2010 Nov; 151(3):232-8. PubMed ID: 20813001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G
    Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of ZAP-70 in patients with chronic lymphocytic leukemia.
    Marjanovic G; Stanojevic I; Jankovic-Velickovic Lj; Hubl W; Marjanovic V
    J BUON; 2008; 13(4):543-6. PubMed ID: 19145677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
    Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
    Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate-stimulated peripheral blood cells.
    Sánchez J; Aventín A
    Cancer Genet Cytogenet; 2007 May; 175(1):57-60. PubMed ID: 17498559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
    Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
    Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.
    Ma W; Kantarjian H; O'Brien S; Jilani I; Zhang X; Estrov Z; Ferrajoli A; Keating M; Giles F; Albitar M
    Cancer; 2008 Mar; 112(6):1306-12. PubMed ID: 18224667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD+ metabolism in lymphocytes of patients affected by B-cell chronic lymphocytic leukaemia.
    Polzonetti V; Pucciarelli S; Signorello L; Vita A; Vincenzetti S; Natalini P
    Int J Immunopathol Pharmacol; 2004; 17(3 Suppl):1-6. PubMed ID: 16857098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitric oxide in supernatants of leukocytes and the serum of patients with B-CLL].
    Jabłońska E; Kiersnowska-Rogowska B; Puzewska W; Rogowski F; Parfieńczyk A
    Przegl Lek; 2006; 63(12):1286-90. PubMed ID: 17642141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.